BIOENGINEER

Immune Cells That Attack the Heart: Multi-Omics Study Reveals Signature of Checkpoint Inhibitor Myocarditis

A multi-omics study identifies ISG15-positive CD8 T cells and a CCL2-CCR2-mediated inflammatory loop as drivers of immune ...
BIOENGINEER

Immune Checkpoint Inhibitor Combos Ranked for Liver Cancer in Major Analysis

A network meta-analysis of eight randomized trials finds that immune checkpoint inhibitors combined with anti-VEGF therapy ...

Scientists identify clues to making immunotherapy more effective against glioblastoma

Two new studies led by researchers at the UCLA Health Jonsson Comprehensive Cancer Center provide new insight into how the ...

IFx 2.0 Market Size and Sales Forecast in the 7MM - 2034 | Phase III Momentum and Checkpoint Inhibitor Combinations Expand Commercial Potential

Late-stage development, KEYTRUDA combination potential, orphan drug advantages and multiple tumor expansion position IFx-2.0 for faster adoption and portfolio returns.Dublin, Oct. 13, 2026 (GLOBE ...
Healio

Neoadjuvant immune checkpoint inhibitor therapy improves outcomes in early breast cancer

Please provide your email address to receive an email when new articles are posted on . Adding immune checkpoint inhibitors to neoadjuvant chemotherapy benefited certain patients with early-stage ...
Forbes

Overcoming Resistance to Checkpoint Inhibitor Cancer Therapy

Checkpoint inhibitors are a groundbreaking class of cancer treatment, but they come with two frustrating challenges. In some cases, tumors show no initial response, rendering the therapy ineffective ...
Medical Xpress

Discovery could improve immune checkpoint inhibitor safety

For many people diagnosed with cancer, treatment with immune checkpoint inhibitors (ICIs) has dramatically extended lives. Some of these treatments, such as Keytruda and Opdivo, have become familiar ...
GEN

Immune Checkpoint Inhibitor Extends Tumor Residence Time for Cancer Therapy

Cancer immunotherapy has historically focused on harnessing the ability of T cells to recognize and attack cancer cells. Adaptive immune checkpoint inhibitors (ICIs) unleash tumor-infiltrating ...
Healio

Checkpoint inhibition can be ‘like pouring lighter fluid onto the fire’ of inflammation

Please provide your email address to receive an email when new articles are posted on . DESTIN, Fla. — Inflammatory arthritis as a result of immune checkpoint cancer therapy remains a pressing ...

Checkpoint Inhibitor Refractory Cancer - 7MM Market Insights, Epidemiology, and Market Forecast - 2036 | Rising Resistance Unlocks Next-Generation Immunotherapy Growth

ICI unmet need through differentiated, biomarker-guided therapies, strategic pipeline prioritization, competitive benchmarking, and market access planning across the 7MM.Dublin, Sept. 30, 2026 (GLOBE ...
PR Newswire

TuHURA Biosciences Receives New U.S. Patent Broadening Coverage for its VISTA Inhibitor, TBS-2025

TuHURA Biosciences, Inc. (NASDAQ:HURA) ("TuHURA" or the "Company"), a Phase 3 immuno-oncology company developing novel ...
Nature

Immune Checkpoint Inhibitor-Induced Autoimmune Diabetes

Immune checkpoint inhibitors have revolutionised oncology by unleashing T cell–mediated antitumour responses through blockade of inhibitory receptors such as PD-1 and CTLA-4. A rare but severe ...